Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 6
2018 6
2019 9
2020 9
2021 13
2022 5
2023 21
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Treatment Strategy for Rifampin-Susceptible Tuberculosis.
Paton NI, Cousins C, Suresh C, Burhan E, Chew KL, Dalay VB, Lu Q, Kusmiati T, Balanag VM, Lee SL, Ruslami R, Pokharkar Y, Djaharuddin I, Sugiri JJR, Veto RS, Sekaggya-Wiltshire C, Avihingsanon A, Sarin R, Papineni P, Nunn AJ, Crook AM; TRUNCATE-TB Trial Team. Paton NI, et al. Among authors: sekaggya wiltshire c. N Engl J Med. 2023 Mar 9;388(10):873-887. doi: 10.1056/NEJMoa2212537. Epub 2023 Feb 20. N Engl J Med. 2023. PMID: 36808186 Free PMC article. Clinical Trial.
Target product profiles: tests for tuberculosis treatment monitoring and optimization.
Gupta-Wright A, den Boon S, MacLean EL, Cirillo D, Cobelens F, Gillespie SH, Kohli M, Ruhwald M, Savic R, Brigden G, Gidado M, Goletti D, Hanna D, Hasan R, Hewison C, Koura KG, Lienhardt C, Lungu P, McHugh TD, McKenna L, Scott C, Scriba T, Sekaggya-Wiltshire C, Kasaeva T, Zignol M, Denkinger CM, Falzon D. Gupta-Wright A, et al. Among authors: sekaggya wiltshire c. Bull World Health Organ. 2023 Nov 1;101(11):730-737. doi: 10.2471/BLT.23.290901. Epub 2023 Oct 4. Bull World Health Organ. 2023. PMID: 37961060 Free PMC article.
Erratum for Sekaggya-Wiltshire et al., "Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?".
Sekaggya-Wiltshire C, Chirehwa M, Musaazi J, von Braun A, Buzibye A, Muller D, Gutteck U, Motta I, Calcagno A, Fehr JS, Kambugu A, Castelnuovo B, Lamorde M, Denti P. Sekaggya-Wiltshire C, et al. Antimicrob Agents Chemother. 2020 Mar 24;64(4):e00315-20. doi: 10.1128/AAC.00315-20. Print 2020 Mar 24. Antimicrob Agents Chemother. 2020. PMID: 32209563 Free PMC article. No abstract available.
Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard- versus high-dose rifampicin.
Kengo A, Nabisere R, Gausi K, Musaazi J, Buzibye A, Omali D, Aarnoutse R, Lamorde M, Dooley KE, Sloan DJ, Denti P, Sekaggya-Wiltshire C. Kengo A, et al. Among authors: sekaggya wiltshire c. Antimicrob Agents Chemother. 2023 Nov 15;67(11):e0043023. doi: 10.1128/aac.00430-23. Epub 2023 Oct 18. Antimicrob Agents Chemother. 2023. PMID: 37850738 Free PMC article. Clinical Trial.
Meta-analysis of genome-wide association studies of stable warfarin dose in patients of African ancestry.
Asiimwe IG, Blockman M, Cavallari LH, Cohen K, Cupido C, Dandara C, Davis BH, Jacobson B, Johnson JA, Lamorde M, Limdi NA, Morgan J, Mouton JP, Muyambo S, Nakagaayi D, Ndadza A, Okello E, Perera MA, Schapkaitz E, Sekaggya-Wiltshire C, Semakula JR, Tatz G, Waitt C, Yang G, Zhang EJ, Jorgensen AL, Pirmohamed M. Asiimwe IG, et al. Among authors: sekaggya wiltshire c. Blood Adv. 2024 Oct 22;8(20):5248-5261. doi: 10.1182/bloodadvances.2024014227. Blood Adv. 2024. PMID: 39163621 Free PMC article.
Optimal therapy for multidrug-resistant tuberculosis and HIV.
Mayanja-Kizza H, Sekaggya-Wiltshire C, Kassa D. Mayanja-Kizza H, et al. Among authors: sekaggya wiltshire c. Lancet. 2020 Aug 8;396(10248):363-365. doi: 10.1016/S0140-6736(20)31688-3. Lancet. 2020. PMID: 32771093 No abstract available.
71 results